Ranbaxy wins patent case against Pfizer

By agencies   |   Thursday, 10 November 2005, 20:30 IST
Printer Print Email Email
MUMBAI: IndiaÂ’s biggest pharma company Ranbaxy Laboratories Ltd. today said it had won a case against Pfizer Inc. on a process patent for cholesterol drug Atorvastatin in Norway. Pfizer markets the drug as Lipitor in the U.S. The Norwegian court found non-infringement by Ranbaxy of one key process patent, though Ranbaxy's product was found to infringe another Pfizer patent covering a particular intermediate compound. Ranbaxy said it would appeal against that judgment. Two other Liptior patents were at issue but were not ruled upon, Ranbaxy said in a statement.